UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 5, 2004
NovaMed, Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 0-26625 | 36-4116193 | ||
| (State or Other Jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
| 980 North Michigan Avenue, Suite 1620, Chicago, Illinois | 60611 | |||
| (Address of Principal Executive Offices) | (Zip Code) | |||
Registrant’s telephone number, including area code (312) 664-4100
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
| Exhibit Number |
Title | |||
| 99.1 | Press release of NovaMed, Inc. dated May 5, 2004 | |||
Item 12. Results of Operations & Financial Condition.
The following information is furnished pursuant to Item 12. “Results of Operations & Financial Condition” in accordance with SEC Release No. 33-8216.
On May 5, 2004, NovaMed, Inc. issued a press release announcing its results of operations for the period ended March 31, 2004. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NovaMed, Inc. | ||||
| Dated: May 5, 2004 |
By: |
/s/ Stephen J. Winjum | ||
| Stephen J. Winjum President and Chief Executive Officer | ||||
3
EXHIBIT INDEX
| Exhibit No. |
Exhibit | |
| 99.1 | Press Release of NovaMed, Inc. dated May 5, 2004. | |
4